The role of D1-D2 receptor hetero-dimerization in the mechanism of action of clozapine
- PMID: 18550344
- DOI: 10.1016/j.euroneuro.2008.05.001
The role of D1-D2 receptor hetero-dimerization in the mechanism of action of clozapine
Abstract
Clozapine is effective although still not perfect drug used to treat schizophrenia. The precise mechanism of its action is not known. Here we show that there are two binding sites for clozapine at the dopamine D1 and D2 receptors, and the affinity of D1R strongly depended on whether the receptor was present alone or together with D2R (or its genetic variant D2Ser311Cys) in the cell membrane, pointing to the role of receptor hetero-dimerization in the observed phenomenon. The use of fluorescence resonance energy transfer (FRET) technology, observed via fluorescence lifetime microscopy of the single cell, indicated that low concentration of clozapine (10(-9) M), sufficient to saturate the high affinity site, uncoupled the D1R-D2R hetero-dimers. Therefore it has been concluded that clozapine might antagonize the effect of concomitant stimulation of both dopamine receptors, which has been shown previously to enhance the formation of hetero-dimers and to stimulate the calcium signaling pathway.
Similar articles
-
Mechanism of action of clozapine in the context of dopamine D1-D2 receptor hetero-dimerization--a working hypothesis.Pharmacol Rep. 2008 Sep-Oct;60(5):581-7. Pharmacol Rep. 2008. PMID: 19066405 Review.
-
Effect of clozapine on the dimerization of serotonin 5-HT(2A) receptor and its genetic variant 5-HT(2A)H425Y with dopamine D(2) receptor.Eur J Pharmacol. 2011 Jun 1;659(2-3):114-23. doi: 10.1016/j.ejphar.2011.03.038. Epub 2011 Apr 9. Eur J Pharmacol. 2011. PMID: 21496455
-
Fluorescence studies reveal heterodimerization of dopamine D1 and D2 receptors in the plasma membrane.Biochemistry. 2006 Jul 25;45(29):8751-9. doi: 10.1021/bi060702m. Biochemistry. 2006. PMID: 16846218
-
Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy?Biol Psychiatry. 1998 Jan 15;43(2):79-83. doi: 10.1016/S0006-3223(98)00226-1. Biol Psychiatry. 1998. PMID: 9474440 Clinical Trial.
-
Differences in efficacy on substance abuse between risperidone and clozapine supports the importance of differential modulation of dopaminergic neurotransmission.Psychopharmacol Bull. 2009;42(4):40-52. Psychopharmacol Bull. 2009. PMID: 20581792 Review.
Cited by
-
Dopamine receptor homooligomers and heterooligomers in schizophrenia.CNS Neurosci Ther. 2011 Feb;17(1):52-7. doi: 10.1111/j.1755-5949.2010.00228.x. Epub 2010 Dec 28. CNS Neurosci Ther. 2011. PMID: 21199449 Free PMC article. Review.
-
Disrupted-in-schizophrenia1 (DISC1) L100P mutation alters synaptic transmission and plasticity in the hippocampus and causes recognition memory deficits.Mol Brain. 2016 Oct 12;9(1):89. doi: 10.1186/s13041-016-0270-y. Mol Brain. 2016. PMID: 27729083 Free PMC article.
-
Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.Prog Mol Biol Transl Sci. 2013;117:207-65. doi: 10.1016/B978-0-12-386931-9.00009-X. Prog Mol Biol Transl Sci. 2013. PMID: 23663971 Free PMC article. Review.
-
Development of a New Polymeric Nanocarrier Dedicated to Controlled Clozapine Delivery at the Dopamine D2-Serotonin 5-HT1A Heteromers.Polymers (Basel). 2021 Mar 24;13(7):1000. doi: 10.3390/polym13071000. Polymers (Basel). 2021. PMID: 33805130 Free PMC article. Review.
-
Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance.Neuropsychopharmacology. 2014 Jan;39(1):156-68. doi: 10.1038/npp.2013.148. Epub 2013 Jun 18. Neuropsychopharmacology. 2014. PMID: 23774533 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
